RARECHEM AL BI 1305(500579-61-3)
- Name: RARECHEM AL BI 1305
- Synonyms:RARECHEM AL BI 1305;2-FLUORO-4-METHYLBENZOIC ACID ETHYL ESTER;ETHYL 2-FLUORO-4-METHYLBENZOATE;NSC 137163
- Molecular Formula:C10H11FO2
- Molecular Weight:182.195
- CAS Registry Number:500579-61-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.500579-61-3 ethyl 2-fluoro-4-methylbenzoate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.500579-61-3 RARECHEM AL BI 1305
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:RARECHEM AL BI 1305
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.500579-61-3 Ethyl2-fluoro-4-methylbenzoate
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.500579-61-3 RARECHEM AL BI 1305
Assay:98% Appearance:clear liquid Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States] CAS No.500579-61-3 Ethyl2-fluoro-4-methylbenzoate Cas no.500579-61-3 98%
Assay:98% Package:Grams, Kilograms Transportation:According to customer request Application:For R&D
Min. Order:0
Supplier:Win-Win chemical Co.Ltd [
China (Mainland)]
Other Product
- 1395493-27-2/Methyl 4-hydroxy-3-iodoquinoline-8-carboxylate
- 50549-30-9/3-(dimethylamino)-4-methyl-2-Piperidinone
- 129288-44-4/FMOC-O-TERT-BUTYL-L-SERINE N-CARBOXY ANH YDRIDE
- 2299-46-9/20α-Hydroxy Prednisolone
- 1150112-53-0/Chloro[(R)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl)][(1R,2R)-2-(diphenylphosphino)-1,2-diphenylethanamine]ruthenium(II) , tetrakis(pentafluorophenyl)borate, min. 97%
- 53626-54-3/α-[4-(Dimethylamino)cyclohexyl]-α-(2-thienyl)-2-thiophenemethanol
- 95333-49-6/1-[(3-Fluoro-4-hydroxyphenyl)methyl]-1,3-dihydro-2H-imidazole-2-thione
- 35942-94-0/2-Furanethanol, 5-Methyl-
- 1072946-08-7/4-(2-Ethoxy-2-oxoethylcarbamoyl)phenylboronic acid
- 157072-09-8/1-ethenyl-4-[2-(4-ethenylphenyl)ethyl]benzene
- 1446818-54-7/tert-butyl 4-(bis(1-methyl-1H-indazol-5-yl)methyl)piperazine-1-carboxylate
- 1403766-70-0/5-Cyclopropyl-1-Methyl-1H-iMidazole-2-carboxaMidine hydrochloride
- 154206-03-8/(3S,4R)-4-(4-FLUOROPHENYL)PYRROLIDIN-3-AMINE
- 37041-06-8/10-Hydroxy-2,6,7-trimethyl-10H-phenoxaphosphine 10-oxide
- 57274-30-3/1,3,7-Trimethyl-2,4,6,8,9-pentathiaadamantane
- 1267391-08-1/4,4,7-triMethyl-1,2,3,4-tetrahydroisoquinoline
- 357649-93-5/Histone Acetyltransferase Inhibitor IV, CPTH2
- 1256643-67-0/(1-benzyl-1H-imidazol-5-yl)acetonitrile(SALTDATA: HCl)
- 104537-94-2/Methyl 1-[5-(hydroxymethyl)-2-furyl]-9H-beta-carboline-3-carboxylate
- 500579-61-3/RARECHEM AL BI 1305
- 122984-57-0/BCE 001
- 1245647-66-8/2-(2-ethoxy-2-oxoethyl)-4-fluorobenzoicacid
- 444082-02-4/1-Piperidinecarbothioamide,N-2-propenyl-(9CI)
- 782479-05-4/Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 2-[[(4-broMophenyl)sulfonyl]oxy]-6-[[(cyclopentyloxy)carbonyl]aMino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-5,16-dioxo-, Methyl ester, (2S,6S,12Z,13aS,14aR,16aS)-
- 1443049-86-2/2-(4'-Chloro[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
- 10245-70-2/5-Ethoxy-2-phenyl-2H-naphtho[1,8-bc]thiophene
- 55273-33-1/ethyl 2-formamido-3-oxopropanoate
- 6647-92-3/N-(1H-pyrazol-4-yl)acetamide
- 816-05-7/N,N-Dimethylpropionamide Dimethyl Acetal
- 13087-86-0/p-Heptyloxyphenol